GlassScriptPhysician profile
Evan Shreck
NPI 1912360231
$1,044.08
in general payments reported to CMS, 2019-2025
14 companies · $26.86 in 2025
The $26.86 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $597 · 2022: $35.97 · 2023: $215 · 2024: $169 · 2025: $26.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Coloplast Corp | $205.11 | 2021-2025 | |
| Boston Scientific Corporation | $113.78 | 2021 | |
| Endo Pharmaceuticals INC. | $85.81 | 2022-2024 | Aveed, Xiaflex, Edex |
| Dentsply Ih Ab | $54.67 | 2023 | Lofric |
| Sumitomo Pharma America, INC. | $48.24 | 2023-2024 | Gemtesa |
| Axonics, INC. | $48.09 | 2023 | Axonics |
| Dentsply Ih INC. | $45.04 | 2024 | Lofric |
| Telix Pharmaceuticals | $29.29 | 2023 | Illuccix |
| Astellas Pharma US INC | $25.37 | 2024 | Myrbetriq |
| 180 Medical, INC. | $24.06 | 2023 | |
| Pfizer INC. | $21.23 | 2022 | |
| Olympus America INC. | $19.35 | 2024 | Soltive |
| Ferring Pharmaceuticals INC. | $19.04 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Shreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.